Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization.

Wang L, Heidt DG, Lee CJ, Yang H, Logsdon CD, Zhang L, Fearon ER, Ljungman M, Simeone DM.

Cancer Cell. 2009 Mar 3;15(3):207-19. doi: 10.1016/j.ccr.2009.01.018.

2.

Phospholipase D1 drives a positive feedback loop to reinforce the Wnt/beta-catenin/TCF signaling axis.

Kang DW, Lee SH, Yoon JW, Park WS, Choi KY, Min do S.

Cancer Res. 2010 May 15;70(10):4233-42. doi: 10.1158/0008-5472.CAN-09-3470. Epub 2010 May 4.

3.

HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression.

Li Y, Bavarva JH, Wang Z, Guo J, Qian C, Thibodeau SN, Golemis EA, Liu W.

Oncogene. 2011 Jun 9;30(23):2633-43. doi: 10.1038/onc.2010.632. Epub 2011 Feb 14.

4.

Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway.

Tang ZP, Dong QZ, Cui QZ, Papavassiliou P, Wang ED, Wang EH.

PLoS One. 2013 Jun 12;8(6):e63676. doi: 10.1371/journal.pone.0063676. Print 2013.

5.

A novel Wilms tumor 1 (WT1) target gene negatively regulates the WNT signaling pathway.

Kim MS, Yoon SK, Bollig F, Kitagaki J, Hur W, Whye NJ, Wu YP, Rivera MN, Park JY, Kim HS, Malik K, Bell DW, Englert C, Perantoni AO, Lee SB.

J Biol Chem. 2010 May 7;285(19):14585-93. doi: 10.1074/jbc.M109.094334. Epub 2010 Mar 10.

6.

Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.

Chen G, A J, Wang M, Farley S, Lee LY, Lee LC, Sawicki MP.

Mol Cancer Res. 2008 Dec;6(12):1894-907. doi: 10.1158/1541-7786.MCR-07-2206.

7.

Prickle-1 negatively regulates Wnt/beta-catenin pathway by promoting Dishevelled ubiquitination/degradation in liver cancer.

Chan DW, Chan CY, Yam JW, Ching YP, Ng IO.

Gastroenterology. 2006 Oct;131(4):1218-27. Epub 2006 Jul 24.

PMID:
17030191
8.

DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications.

Jiang X, Tan J, Li J, Kivimäe S, Yang X, Zhuang L, Lee PL, Chan MT, Stanton LW, Liu ET, Cheyette BN, Yu Q.

Cancer Cell. 2008 Jun;13(6):529-41. doi: 10.1016/j.ccr.2008.04.019.

9.
10.

Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling.

Leung JY, Kolligs FT, Wu R, Zhai Y, Kuick R, Hanash S, Cho KR, Fearon ER.

J Biol Chem. 2002 Jun 14;277(24):21657-65. Epub 2002 Apr 8.

11.

Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.

Ramachandran I, Thavathiru E, Ramalingam S, Natarajan G, Mills WK, Benbrook DM, Zuna R, Lightfoot S, Reis A, Anant S, Queimado L.

Oncogene. 2012 May 31;31(22):2725-37. doi: 10.1038/onc.2011.455. Epub 2011 Oct 17.

PMID:
22002305
12.

Beta-catenin-independent Wnt pathways: signals, core proteins, and effectors.

James RG, Conrad WH, Moon RT.

Methods Mol Biol. 2008;468:131-44. doi: 10.1007/978-1-59745-249-6_10.

PMID:
19099251
13.

Autolysosomal β-catenin degradation regulates Wnt-autophagy-p62 crosstalk.

Petherick KJ, Williams AC, Lane JD, Ordóñez-Morán P, Huelsken J, Collard TJ, Smartt HJ, Batson J, Malik K, Paraskeva C, Greenhough A.

EMBO J. 2013 Jul 3;32(13):1903-16. doi: 10.1038/emboj.2013.123. Epub 2013 Jun 4.

14.

ATDC/TRIM29 phosphorylation by ATM/MAPKAP kinase 2 mediates radioresistance in pancreatic cancer cells.

Wang L, Yang H, Palmbos PL, Ney G, Detzler TA, Coleman D, Leflein J, Davis M, Zhang M, Tang W, Hicks JK, Helchowski CM, Prasad J, Lawrence TS, Xu L, Yu X, Canman CE, Ljungman M, Simeone DM.

Cancer Res. 2014 Mar 15;74(6):1778-88. doi: 10.1158/0008-5472.CAN-13-2289. Epub 2014 Jan 27.

15.

ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis.

Wang L, Yang H, Abel EV, Ney GM, Palmbos PL, Bednar F, Zhang Y, Leflein J, Waghray M, Owens S, Wilkinson JE, Prasad J, Ljungman M, Rhim AD, Pasca di Magliano M, Simeone DM.

Genes Dev. 2015 Jan 15;29(2):171-83. doi: 10.1101/gad.253591.114.

16.

Parathyroid hormone receptor directly interacts with dishevelled to regulate beta-Catenin signaling and osteoclastogenesis.

Romero G, Sneddon WB, Yang Y, Wheeler D, Blair HC, Friedman PA.

J Biol Chem. 2010 May 7;285(19):14756-63. doi: 10.1074/jbc.M110.102970. Epub 2010 Mar 8.

17.

Stabilization of beta-catenin induces pancreas tumor formation.

Heiser PW, Cano DA, Landsman L, Kim GE, Kench JG, Klimstra DS, Taketo MM, Biankin AV, Hebrok M.

Gastroenterology. 2008 Oct;135(4):1288-300. doi: 10.1053/j.gastro.2008.06.089. Epub 2008 Jul 9.

18.

Sequential activation and inactivation of Dishevelled in the Wnt/beta-catenin pathway by casein kinases.

Bernatik O, Ganji RS, Dijksterhuis JP, Konik P, Cervenka I, Polonio T, Krejci P, Schulte G, Bryja V.

J Biol Chem. 2011 Mar 25;286(12):10396-410. doi: 10.1074/jbc.M110.169870. Epub 2011 Feb 1.

19.

Nuclear Dvl, c-Jun, beta-catenin, and TCF form a complex leading to stabilization of beta-catenin-TCF interaction.

Gan XQ, Wang JY, Xi Y, Wu ZL, Li YP, Li L.

J Cell Biol. 2008 Mar 24;180(6):1087-100. doi: 10.1083/jcb.200710050. Epub 2008 Mar 17.

20.

Frat oncoproteins act at the crossroad of canonical and noncanonical Wnt-signaling pathways.

van Amerongen R, Nawijn MC, Lambooij JP, Proost N, Jonkers J, Berns A.

Oncogene. 2010 Jan 7;29(1):93-104. doi: 10.1038/onc.2009.310. Epub 2009 Oct 5.

PMID:
19802005
Items per page

Supplemental Content

Write to the Help Desk